Stora Enso's newsletter for stakeholders
Topics covered:
Living the code of conduct
Piloting WWF methodology for assessing landscape changes
Multi-stakeholder dialogue on plantations
A transparent process for forest certification
Highly rated climate strategy
A new solution for sustainable shelves
Building up commitment through e-learning
Each year we publish an annual report along with a graduate schools yearbook to give you an insight into our many research projects, results and activities at DTU Chemical and Biochemical Engineering.
FLSmidth annual report for 2013 was released on 13 February 2014. Best viewed on a full screen mode, this annual report informs the reader about how well FLSmidth's business is doing financially, as well as FLSmidth's growth strategies and new financial targets projected for the next year.
Chicago TREND (Transforming Retail Economics of Neighborhood Development) combines innovative predictive analytics, deal brokering and financial products to support "retail on the leading edge" of emerging neighborhood markets. The new initiative - including partnerships with ICSC, Nielsen, Econsult Solutions and leading retailers and developers - aims to enable retailers, developers, investors and neighborhoods to better target particular types of retail to specific changing neighborhoods offering retail opportunity that will help drive the neighborhood change. The initiative is led by Lyneir Richardson. To discuss potential retail development and partnership opportunities, please contact him at lyneir@rw-ventures.com.
Solutions Catalog # 1 by ISIS Papyrus Software
Learn More about successful Customer Implement
in various Industries and how the Papyrus Platform for
Inbound and Outbound Business Communication and
Process Management will make your organization
more flexible, efficient and responsive to customer needs.
The International Comparative Legal Guide to Corporate Tax 2014Julia Smirnova
GLG published its 2014 edition of the ICLG: Corporate Tax which has been fully revised and updated to cover the key issues of current applicable regulation, including full analysis of important aspects of cross-border transactions and international law. With contributions from over 40 leading law firms worldwide, the guide offers concise and comprehensive guidelines for global investors operating across various jurisdictions. Lidings’ partner, head of Tax and Customs practice Stepan Guzey has authored exclusive coverage of Russian regulation.
Med dette nyhedsbrev præsenteres du for væsentlige bekendtgørelser, rapporter og andre informationer med relevans for kemisk orienterede virksomheder, virksomheder der leverer ingredienser til healthcare og fødevarer samt transport logistik. Al lovgivning er samlet i en lovliste, som følger nyhedsbrevet.
Med dette nyhedsbrev præsenteres du for væsentlige bekendtgørelser, rapporter og andre informationer med relevans for kemisk orienterede virksomheder, virksomheder der leverer ingredienser til healthcare og fødevarer samt transport logistik. Al lovgivning er samlet i en lovliste, som følger nyhedsbrevet.
From october 2009 - through march 2010 I worked on a project to identify and document potential areas of cooperation within research, development and especially innovation between Denmark and Brazil. This presentation highlights the focus areas identified, synergies found compared to some Brazilian top universities in the south-east and south part of Brazil. The presentation exist only in Danish, but many terms used are English.
Stora Enso's newsletter for stakeholders
Topics covered:
Living the code of conduct
Piloting WWF methodology for assessing landscape changes
Multi-stakeholder dialogue on plantations
A transparent process for forest certification
Highly rated climate strategy
A new solution for sustainable shelves
Building up commitment through e-learning
Each year we publish an annual report along with a graduate schools yearbook to give you an insight into our many research projects, results and activities at DTU Chemical and Biochemical Engineering.
FLSmidth annual report for 2013 was released on 13 February 2014. Best viewed on a full screen mode, this annual report informs the reader about how well FLSmidth's business is doing financially, as well as FLSmidth's growth strategies and new financial targets projected for the next year.
Chicago TREND (Transforming Retail Economics of Neighborhood Development) combines innovative predictive analytics, deal brokering and financial products to support "retail on the leading edge" of emerging neighborhood markets. The new initiative - including partnerships with ICSC, Nielsen, Econsult Solutions and leading retailers and developers - aims to enable retailers, developers, investors and neighborhoods to better target particular types of retail to specific changing neighborhoods offering retail opportunity that will help drive the neighborhood change. The initiative is led by Lyneir Richardson. To discuss potential retail development and partnership opportunities, please contact him at lyneir@rw-ventures.com.
Solutions Catalog # 1 by ISIS Papyrus Software
Learn More about successful Customer Implement
in various Industries and how the Papyrus Platform for
Inbound and Outbound Business Communication and
Process Management will make your organization
more flexible, efficient and responsive to customer needs.
The International Comparative Legal Guide to Corporate Tax 2014Julia Smirnova
GLG published its 2014 edition of the ICLG: Corporate Tax which has been fully revised and updated to cover the key issues of current applicable regulation, including full analysis of important aspects of cross-border transactions and international law. With contributions from over 40 leading law firms worldwide, the guide offers concise and comprehensive guidelines for global investors operating across various jurisdictions. Lidings’ partner, head of Tax and Customs practice Stepan Guzey has authored exclusive coverage of Russian regulation.
Med dette nyhedsbrev præsenteres du for væsentlige bekendtgørelser, rapporter og andre informationer med relevans for kemisk orienterede virksomheder, virksomheder der leverer ingredienser til healthcare og fødevarer samt transport logistik. Al lovgivning er samlet i en lovliste, som følger nyhedsbrevet.
Med dette nyhedsbrev præsenteres du for væsentlige bekendtgørelser, rapporter og andre informationer med relevans for kemisk orienterede virksomheder, virksomheder der leverer ingredienser til healthcare og fødevarer samt transport logistik. Al lovgivning er samlet i en lovliste, som følger nyhedsbrevet.
From october 2009 - through march 2010 I worked on a project to identify and document potential areas of cooperation within research, development and especially innovation between Denmark and Brazil. This presentation highlights the focus areas identified, synergies found compared to some Brazilian top universities in the south-east and south part of Brazil. The presentation exist only in Danish, but many terms used are English.
Med dette nyhedsbrev præsenteres du for væsentlige bekendtgørelser, rapporter og andre informationer med relevans for kemisk orienterede virksomheder, virksomheder der leverer ingredienser til healthcare og fødevarer samt transport logistik. Al lovgivning er samlet i en lovliste, som følger nyhedsbrevet.
Oplægget blev holdt ved InfinIT-konferencen "Design og udvikling af velfærdsteknologiske IT-løsninger", der blev afholdt den 21. november 2013. Læs mere om arrangementet på http://infinit.dk/dk/hvad_kan_vi_goere_for_dig/viden/reportager/velfaerdsteknologi_i_fokus.htm
Oplægget blev holdt ved InfinIT-arrangementet "Sammenhængende patientforløb, sundheds-processer og it" afholdt den 20. april 2012. Læs mere om arrangementet på http://www.infinit.dk/dk/hvad_kan_vi_goere_for_dig/viden/reportager/en_forandret_sundhedssektor_med_it.htm
2. Agenda Kort oversigt Stigende sundhedsudgifter = nye forretningsmuligheder Markedet for Exiqons teknologi og produkter Investerings casen Life Sciences: Høj organisk vækst Diagnostics: På tærsklen til gennembrud Finansielle highlights for H1 2011 Investorinformation
11. I Danmark bruges årligt 1,1 milliard på kemoterapi, men kun 25-30% af den ordinerede kemoterapi har effekt – kun bivirkninger
12. I Danmark er antallet af patienter, der modtager kemoterapi øget med 78% fra 2004 til 20092
13. Udfordringen med de store sundhedsudgifter adresseres i det nye regeringsgrundlag (tidlig diagnose samt valg af rigtig behandling)Berlingske Tidende 26 april, 2010 1: Keenan. Health Affairs 2008; 27:145-155 2: Landspatientregisteret
23. Markedet for genetisk analyse er på > 60 milliarder DKK 10 > $ 12 milliarder er værdien af markedet for DNA og RNA analyse Forskningsmarkedet ~$ 5,5 milliarder Anvendt testing > $ 1,1 milliarder Molekylær diagnostik > $ 5,4 milliarder Infektionssygdomme $ 3 mia. Kriminalteknik > $ 400 mio. RNA DNA mRNA ~ $ 2 mia. Kræftdiagnose $ 600 mio. SNP/CNV Miljø Prenatal diagnostik > $ 1 mia. Fødevareanalyse $ 350 mio. miRNA $ 60 mio Sekvensering $ 1,3 mia. siRNA $ 800 mio Epigenomics $ 900 mia. Pharmacogenomics > $ 800 mio. Biosikkerhed Addressed through partners/licensees (e.g. Roche, Becton Dickinson, Life Technologies) Exiqon direkte Endnu ikke med LNA™
24. Agenda Kort oversigt Stigende sundhedsudgifter = nye forretningsmuligheder Markedet for Exiqons teknologi og produkter Investerings casen Life Sciences: Høj organisk vækst Diagnostics: På tærsklen til gennembrud Finansielle highlights for H1 2011 Investorinformation
25. Investerings-casen – en forretningsmodel med synergier 12 Life Sciences produkterne tjener som platform for ny molekylær Diagnostics Life Sciences produkter benyttes til at udføre Services Diagnostics leverer data, der faciliterer salget af Life Sciences produkterne Services tiltrækker nye kunder til Life Sciences produkterne LNA™ Diagnostics drager fordel af know-how tilegnet i Services Services leverer opdagelser af nye biomarkører, som kunderne kan benytte i molekylær Diagnostics
28. Agenda Kort oversigt Stigende sundhedsudgifter = nye forretningsmuligheder Markedet for Exiqons teknologi og produkter Investerings casen Life Sciences: Høj organisk vækst Diagnostics: På tærsklen til gennembrud Finansielle highlights for H1 2011 Investorinformation
33. Nye produkter vil sikre fortsat vækst 17 Baseret på input fra 20.000 forskere er følgende identificeret som top 3 behov i markedet: Produkt markedsført oktober 2011 Produkt markedsføres 2012 Produkt markedsført august 2011 Relative enheder Kilde: SelectBiosciences, August 2011
34. Agenda Kort oversigt Stigende sundhedsudgifter = nye forretningsmuligheder Markedet for Exiqons teknologi og produkter Investerings casen Life Sciences: Høj organisk vækst Diagnostics: På tærsklen til gennembrud Finansielle highlights for H1 2011 Investorinformation
46. Der er et væsentligt udækket behov for at identificere patienter tidligt samt patienter med tilbagevendende modermærkekræft. Markedspotentialet kan potentielt nå 370 mUSD.
47. Første discovery data fra NYU center studie præsenteret mundtligt på ASCO konference i juni 2011:
52. 22 Fortsat vækst – Fortsat stærk vækst i omsætning, 21% over H1 2010 I Q2 var omsætning påvirket af en periodisering af en underskrevet kontrakt Forbedret bruttoresultat – bruttoresultat for H1 2011 steg 21% til DKK 28,4m (DKK 23,5m) I Q2 steg bruttoresultatet 13% til DKK 13,9m (DKK 12,4m) Reducerede omkostninger – bortset fra engangsomkostning tilretssag.Totale driftsomkostninger H1 2011 uændret på 44,7m (DKK 44,6m) Forbedret EBITDA - EBITDA for H1 2011 forbedredes med 27% til DKK -11,8m (DKK – 16,1m) på trods af engangomkostning til retssag I Q2 EBITDA faldt -32% til DKK -10,3m (DKK – 7,8m), men steg 44% når bortses fra engangsomkostning til retssag Nettoresultat påvirket af engangsomkostning – Nettoresultatet af fortsættende virksomhed var i H1 2011 DKK -17,7m (DKK -22,8m) I Q2 var nettoresultatet af fortsættende virksomhed DKK -12,8m (DKK 0,1m)) Basis EPS på DKK -0,53 pr. aktie (DKK -0.71 pr. aktie) H1 2011 - Finansielle highlights 5,25 DKK = 1 USD
53. Agenda Kort oversigt Stigende sundhedsudgifter = nye forretningsmuligheder Markedet for Exiqons teknologi og produkter Investerings casen Life Sciences: Høj organisk vækst Diagnostics: På tærsklen til gennembrud Finansielle highlights for H1 2011 Investorinformation